NCT03773003 Research for Pathophysiology of Cancer Related Fatigue (CRF) and Chronic Fatigue (CFS/ME)
| NCT ID | NCT03773003 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universität des Saarlandes |
| Condition | Cancer Related Fatigue |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2021-07-20 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2021-07-20 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Research for Pathophysiology of Cancer Related Fatigue (CRF) and Chronic Fatigue Syndrome (CFS/ME) by Lipidomics, Metabolomics, Intestinal and Peritoneal Microbiome Analysis and Exome Analysis and Investigation of a Possible Benefit of Probiotics.
Eligibility Criteria
Inclusion Criteria: * histologically, cytologically or radiologically confirmed tumor disease * indication for chemotherapy * Written consent to participation Exclusion Criteria: * chronic-inflammatory bowel disease * pregnancy
Contact & Investigator
Michael Jelden, MD
PRINCIPAL INVESTIGATOR
University Hospital, Saarland
Frequently Asked Questions
Who can join the NCT03773003 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Cancer Related Fatigue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03773003 currently recruiting?
Yes, NCT03773003 is actively recruiting participants. Contact the research team at michael.jelden@uks.eu for enrollment information.
Where is the NCT03773003 trial being conducted?
This trial is being conducted at Homburg, Germany.
Who is sponsoring the NCT03773003 clinical trial?
NCT03773003 is sponsored by Universität des Saarlandes. The principal investigator is Michael Jelden, MD at University Hospital, Saarland. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.